Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D P Zarowny

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Canadian Medical Association Journal|March 24, 2010
Comparative bioavailabilityD P Zarowny
Canadian Medical Association Journal|December 22, 1979
Clinical pharmacology and therapeutics of benzodiazepinesD P Zarowny
Canadian Medical Association Journal|August 15, 1984
Accutane Roche: risk of teratogenic effectsD P Zarowny
Canadian Medical Association Journal|March 24, 2010
Comparative bioavailabilityD P Zarowny
Canadian Medical Association Journal|September 26, 1970
Acute subdural hematoma during maintenance hemodialysisD P Zarowny, I Rose
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 17, 1998
Guidelines for antiretroviral therapy for HIV infection. Canadian HIV Trials Network Antiretroviral Working GroupA R Rachlis, D P Zarowny
The Journal of Investigative Dermatology|April 1, 1975
Evaluation of the effectiveness of griseofulvin, tolnaftate, and placebo in the topical therapy of superficial dermatophytosesD P Zarowny, R S Rogers, J P Tindall
Canadian Medical Association Journal|August 5, 1972
BioavailabilityR O Davies, D P Zarowny, H R Robin, et al.
The Journal of Infectious Diseases|January 7, 1998
Determinants of rifabutin-associated uveitis in patients treated with rifabutin, clarithromycin, and ethambutol for Mycobacterium avium complex bacteremia: a multivariate analysis. Canadian HIV Trials Network Protocol 010 Study GroupS D Shafran, J Singer, D P Zarowny, et al.
The New England Journal of Medicine|August 8, 1996
A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study GroupS D Shafran, J Singer, D P Zarowny, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Canadian Medical Association Journal|March 24, 2010
Comparative bioavailabilityD P Zarowny
Canadian Medical Association Journal|December 22, 1979
Clinical pharmacology and therapeutics of benzodiazepinesD P Zarowny
Canadian Medical Association Journal|August 15, 1984
Accutane Roche: risk of teratogenic effectsD P Zarowny
Canadian Medical Association Journal|March 24, 2010
Comparative bioavailabilityD P Zarowny
Canadian Medical Association Journal|September 26, 1970
Acute subdural hematoma during maintenance hemodialysisD P Zarowny, I Rose
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 17, 1998
Guidelines for antiretroviral therapy for HIV infection. Canadian HIV Trials Network Antiretroviral Working GroupA R Rachlis, D P Zarowny
The Journal of Investigative Dermatology|April 1, 1975
Evaluation of the effectiveness of griseofulvin, tolnaftate, and placebo in the topical therapy of superficial dermatophytosesD P Zarowny, R S Rogers, J P Tindall
Canadian Medical Association Journal|August 5, 1972
BioavailabilityR O Davies, D P Zarowny, H R Robin, et al.
The Journal of Infectious Diseases|January 7, 1998
Determinants of rifabutin-associated uveitis in patients treated with rifabutin, clarithromycin, and ethambutol for Mycobacterium avium complex bacteremia: a multivariate analysis. Canadian HIV Trials Network Protocol 010 Study GroupS D Shafran, J Singer, D P Zarowny, et al.
The New England Journal of Medicine|August 8, 1996
A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study GroupS D Shafran, J Singer, D P Zarowny, et al.
Pageof 2